We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Geoffrey G. Schofield is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
1990 — 1993 |
Schofield, Geoffrey G |
R29Activity Code Description: Undocumented code - click on the grant title for more information. |
Neuronal Excitability of Spontaneously Hypertensive @ Tulane University of Louisiana
membrane channels; neurons; hypertension; electrophysiology; sympathetic ganglion; hydralazine; antihypertensive agents; disease /disorder model; drug screening /evaluation; molecular pathology; spontaneous hypertensive rat;
|
1 |
1994 |
Schofield, Geoffrey G |
R29Activity Code Description: Undocumented code - click on the grant title for more information. |
Neuronal Excitability of Spontaneously Hypertensive Rats @ Tulane University of Louisiana |
1 |
1995 — 1998 |
Schofield, Geoffrey G |
R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
Ca++ Currents--Renal Sympathetic Neurons in Hypertension @ Tulane University of Louisiana
Recent work has demonstrated that increased sympathetic nerve activity and/or increased norepinephrine (NE) release is associated with the development or maintenance of hypertension in the spontaneously hypertensive rat (SHR). These effects are likely to encompass the neurons which control kidney function and the increased NE release per impulse could be associated with an enhancement or defective regulation of the Ca2+ current in the SHR. Thus the hypothesis to be tested is that: the SHR exhibits an alteration in the properties and/or neurotransmitter modulation of voltage-dependent Ca2+ channels in renal efferent sympathetic neurons, and that these alterations contribute to the development and maintenance of hypertension in the SHR. The specific aims of the proposal are to: compare the properties of and neurotransmitter modulation of Ca2+ currents of renal efferent sympathetic neurons of SHR and age matched WKY rats using the whole-cell patch-clamp technique. The Ca2+ channels will be characterized in terms of: channel density, single channel conductance and open probability, activation and inactivation voltage ranges, voltage-dependence of current time course and Ca2+ channel type. Ca2+ channel modulation will be investigated by constructing concentration response curves for NE, adenosine and somatostatin, agents known to inhibit Ca2+ currents and/or CA2+ dependent exocytotic NE release. The effects of nitric oxide donors which can increase Ca2+ currents and/or Ca2+-dependent exocytotic NE release will be investigated. The role of signal transduction mechanisms in the neurotransmitter modulation of the Ca2+ channels will be investigated using nonhydolyzable guanine nucleotide analogs and pertussis toxin as well as activators and inhibitors of protein kinases. Parallel investigations of neurons which do not innervate the kidney will be undertaken to investigate if alterations of the biophysical properties of the Ca2+ channels of SHR are unique to renal efferent sympathetic neurons. Alterations in Ca2+ channel behavior which are causative of the hypertension will be differentiated from those that are secondary to the hypertension by 1) using SHR and WKY rats from different age groups, alterations of Ca2+ channels not causative of hypertension would not be expected in SHR in the "prehypertensive" stage and 2) chronic antihypertensive drug therapy will be used to differentiate changes in Ca2+ channel behavior which are secondary to the hypertension. The experiments are expected to yield valuable data concerning the cellular mechanism(s) of increased NE release from key sympathetic neurons in hypertension.
|
1 |